Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles E. Sheedy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Emerson Jorden - $310K in AURX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charles E. Sheedy?
Charles E. Sheedy is a corporate insider, tracked as 10% Owner of Nuo Therapeutics, Inc. (AURX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Charles E. Sheedy last file a Form 4?
The only primary Form 4 on record is dated 1 August 2025.
Has Charles E. Sheedy been buying or selling stock?
Recorded transactions: 1 open-market purchase ($200K) and 0 open-market sales across all tracked filings.
